Fundamentals of liquid biopsies in metastatic prostate cancer: from characterization to stratification.

Current Opinion in Oncology
Lisanne F van DesselMartijn P Lolkema

Abstract

In this review, we provide an overview of the recent developments and prospects on the applications of blood-based liquid biopsies, including circulating tumor DNA and circulating tumor cells, in metastatic prostate cancer. Guidelines and consensus statements have been formulated to standardize preanalytical conditions that affect liquid biopsy analysis. Currently, there are four FDA approved assays for the analysis of liquid biopsies and many quantitative and qualitative assays are being developed. Comprehensive analyses of cell-free tumor DNA (ctDNA) and circulating tumor cells (CTCs) demonstrate that they adequately reflect the genomic makeup of the tumor and may thus complement or even replace tumor biopsies. The assessment of genomic aberrations in ctDNA can potentially predict therapy response and detect mechanisms of resistance. CTC count is not only a strong prognosticator in metastatic prostate cancer but can also measure therapy response. Liquid biopsies may provide a temporal snapshot of the biologic variables that affect tumor growth and progression in metastatic prostate cancer. Liquid biopsies could inform on prognostic, predictive, and response measures. However, prospective clinical trials need to be performed t...Continue Reading

References

Apr 19, 2005·Urology·Jose G MorenoLeon W M M Terstappen
Dec 7, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Daniel C DanilaHoward I Scher
May 25, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jamie R SchoenbornMin Fang
Sep 4, 2014·The New England Journal of Medicine·Emmanuel S AntonarakisJun Luo
May 23, 2015·Cell·Dan RobinsonArul M Chinnaiyan
Nov 6, 2015·Science Translational Medicine·Alessandro RomanelGerhardt Attard
Nov 7, 2015·Cell·UNKNOWN Cancer Genome Atlas Research Network
Jan 6, 2016·Current Opinion in Oncology·Anna BuderMartin Filipits
Jan 10, 2017·Nature·Michael FraserPaul C Boutros
Apr 30, 2017·Cancer Discovery·Jane GoodallUNKNOWN TOPARP-A investigators
May 13, 2017·International Journal of Molecular Sciences·Alison W S LukTherese M Becker
Dec 6, 2017·Journal of the National Cancer Institute·Alexander W WyattMartin E Gleave
Feb 6, 2018·Clinical Chemistry and Laboratory Medicine : CCLM·Marius IlieUNKNOWN STALKLUNG01 and AIR Study Consortium Investigators
Feb 24, 2018·The Journal of Molecular Diagnostics : JMD·Anieta M SieuwertsStefan Sleijfer
Mar 6, 2018·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jason D MerkerNicholas C Turner
Mar 24, 2018·Cancer Genetics·Kristina WartonGoli Samimi
Mar 25, 2018·Current Oncology Reports·Gareth J Morrison, Amir Goldkorn
Mar 27, 2018·International Journal of Cancer. Journal International Du Cancer·Jelena BelicMichael R Speicher
May 10, 2018·Annals of Oncology : Official Journal of the European Society for Medical Oncology·D LorenteJ S de Bono
Aug 11, 2018·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Maryou B LambrosJohann S de Bono
Sep 14, 2018·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Bram De LaereLuc Y Dirix
Oct 9, 2018·The Journal of Molecular Diagnostics : JMD·Silvia R VitaleJohn W M Martens
Oct 12, 2018·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Scott T TagawaParaskevi Giannakakou
Oct 20, 2018·The Journal of Clinical Investigation·Adam SharpStephen R Plymate
Nov 6, 2018·JCI Insight·Atish D ChoudhuryViktor A Adalsteinsson
Dec 6, 2018·Molecular Oncology·Lisanne F van DesselMartijn P Lolkema
Dec 17, 2018·Cancer Genetics·Russell J DiefenbachHelen Rizos
Jan 15, 2019·European Urology·Gillian VandekerkhoveAlexander W Wyatt
Jan 27, 2019·International Journal of Molecular Sciences·Kiki C AndreeLeon W M M Terstappen
Feb 1, 2019·JCI Insight·Emmanuelle HodaraAmir Goldkorn

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Current Problems in Cancer
Beatriz WillsValerie Lee
Oncotarget
Camila Tavares Uchôa GuimarãesDanielle Queiroz Calcagno
Annals of Oncology : Official Journal of the European Society for Medical Oncology
G SiravegnaA Bardelli
Annals of Oncology : Official Journal of the European Society for Medical Oncology
G SiravegnaA Bardelli
© 2021 Meta ULC. All rights reserved